2023 - Research.com Biology and Biochemistry in United States Leader Award
2023 - Research.com Neuroscience in United States Leader Award
2004 - Fellow of the American Association for the Advancement of Science (AAAS)
2000 - Nobel Prize for their discoveries concerning signal transduction in the nervous system
1999 - Member of the National Academy of Medicine (NAM)
1998 - Metlife Foundation Award for Medical Research in Alzheimer's Disease
1994 - Ralph W. Gerard Prize in Neuroscience, Society for Neuroscience
1993 - Karl Spencer Lashley Award, The American Philosophical Society For his pioneering work on the molecular basis of signal transduction and vesicle mobilization in nerve cells
1991 - NAS Award in the Neurosciences, U.S. National Academy of Sciences For his discovery of the central role played by neuronal phosphoproteins in normal brain function as well as in neuropsychiatric and related disorders.
1978 - Member of the National Academy of Sciences
His main research concerns Cell biology, Neuroscience, Biochemistry, Internal medicine and Endocrinology. His Cell biology research integrates issues from Synapsin, Synapsin I, Synaptic vesicle, AMPA receptor and Molecular biology. His study looks at the relationship between Neuroscience and fields such as Synaptic plasticity, as well as how they intersect with chemical problems.
His Biochemistry study frequently draws connections between adjacent fields such as Amyloid precursor protein. His Endocrinology research incorporates elements of Apical membrane, Chloride channel, Na+/K+-ATPase and Membrane potential. His study in Phosphorylation is interdisciplinary in nature, drawing from both Signal transduction and Cytoskeleton.
Paul Greengard mostly deals with Cell biology, Neuroscience, Biochemistry, Phosphorylation and Protein kinase A. His Cell biology study incorporates themes from Synapsin, Synapsin I and Synaptic vesicle. As a part of the same scientific family, Paul Greengard mostly works in the field of Synapsin I, focusing on Neurotransmitter and, on occasion, Neurotransmission.
His biological study deals with issues like Synaptic plasticity, which deal with fields such as Long-term potentiation. His Amyloid precursor protein research extends to the thematically linked field of Biochemistry. Paul Greengard has researched Protein kinase A in several fields, including Substantia nigra and Molecular biology.
His scientific interests lie mostly in Neuroscience, Cell biology, Antidepressant, Dopamine and Medium spiny neuron. His research investigates the connection between Neuroscience and topics such as Dyskinesia that intersect with problems in Direct pathway of movement, Levodopa and Parkinsonism. He is interested in Phosphorylation, which is a branch of Cell biology.
His study on Antidepressant also encompasses disciplines like
Paul Greengard mainly investigates Neuroscience, Cell biology, Antidepressant, Dentate gyrus and Phosphorylation. Many of his studies on Neuroscience apply to Signal transduction as well. His studies deal with areas such as Single-cell analysis, Molecular biology, Presenilin, Polysome and Cell sorting as well as Cell biology.
His Phosphorylation research is classified as research in Biochemistry. His study focuses on the intersection of Biochemistry and fields such as Environmental enrichment with connections in the field of Protein kinase A and Dendritic spine. His work in Long-term potentiation addresses subjects such as Neurotrophic factors, which are connected to disciplines such as Endocrinology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor
Noboru Sato;Laurent Meijer;Laurent Meijer;Leandros Skaltsounis;Paul Greengard.
Nature Medicine (2004)
Regulation of NMDA receptor trafficking by amyloid-beta.
Eric M Snyder;Yi Nong;Claudia G Almeida;Surojit Paul.
Nature Neuroscience (2005)
Synaptic Vesicle Phosphoproteins and Regulation of Synaptic Function
Paul Greengard;Flavia Valtorta;Andrew J. Czernik;Fabio Benfenati.
Intraneuronal Aβ42 Accumulation in Human Brain
Gunnar K. Gouras;Gunnar K. Gouras;Julia Tsai;Jan Naslund;Bruno Vincent.
American Journal of Pathology (2000)
The neurobiology of slow synaptic transmission.
Dichotomous Dopaminergic Control of Striatal Synaptic Plasticity
Weixing Shen;Marc Flajolet;Paul Greengard;D. James Surmeier.
Three-dimensional structure of the catalytic subunit of protein serine/threonine phosphatase-1.
Jonathan Goldberg;Hsien Bin Huang;Young Guen Kwon;Paul Greengard.
A Translational Profiling Approach for the Molecular Characterization of CNS Cell Types
Myriam Heiman;Anne Schaefer;Shiaoching Gong;Jayms D. Peterson.
Indirubins Inhibit Glycogen Synthase Kinase-3β and CDK5/P25, Two Protein Kinases Involved in Abnormal Tau Phosphorylation in Alzheimer's Disease A PROPERTY COMMON TO MOST CYCLIN-DEPENDENT KINASE INHIBITORS?
Sophie Leclerc;Matthieu Garnier;Ralph Hoessel;Doris Marko.
Journal of Biological Chemistry (2001)
Beyond the dopamine receptor: the DARPP-32/protein phosphatase-1 cascade.
Paul Greengard;Patrick B. Allen;Angus C. Nairn.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: